Regulatory tracker: Novavax's updated COVID vaccine delayed in Europe | Fierce Pharma

Quote






Just more evidence that this organization is on a slow shuffle march to the end. Regulatory agencies aren't buying it and neither are investors. The EUA should have shown promise with regulators and investors. However, the lack of approval and no increase in stock value says enough.

Time to make it to the life rafts.
 












Top Bottom
Back
Quote